Estimaciones de analistas de Wall Street para Gevo, Inc. (GEVO): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-09 | $0.04 | ||
| 2026-08-06 | $-0.01 | $-0.02 | +52.2% |
| 2026-05-07 | $-0.05 | $-0.02 | -150.0% |
| 2026-03-05 | $-0.02 | $-0.03 | +33.3% |
| 2025-11-10 | $-0.03 | $-0.04 | +25.0% |
| 2025-08-11 | $0.01 | $-0.06 | +116.7% |
| 2025-05-13 | $-0.09 | $-0.10 | +10.0% |
| 2025-03-27 | $-0.09 | $-0.11 | +18.2% |
Ratios de valoración
| Precio / Valor contable | 1.32 |
| EV / EBITDA | -3.07 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $26.5M | $27.3M | $32.9M | $24.5M | $5.5M | $533000 | $1.2M | $17.2M | $16.9M | $160.6M |
| Coste de Ventas | $37.0M | $38.2M | $41.6M | $36.7M | $15.0M | $7.7M | $8.7M | $12.0M | $12.0M | $112.0M |
| Beneficio Bruto | -$10.5M | -$10.9M | -$8.7M | -$12.3M | -$9.5M | -$7.2M | -$7.5M | $5.2M | $4.9M | $48.5M |
| I+D | $5.2M | $5.2M | $5.4M | $4.0M | $3.5M | $17.4M | $17.5M | $6.6M | $23.7M | $4.5M |
| Generales y Administrativos | $9.0M | $7.5M | $8.1M | $10.1M | $11.2M | $25.5M | $39.9M | $42.6M | $45.8M | $51.2M |
| Gastos Operativos | $13.5M | $12.4M | $13.5M | $14.1M | $17.5M | $53.1M | $95.2M | $87.0M | $95.7M | $67.4M |
| Beneficio Operativo | -$24.0M | -$23.3M | -$22.2M | -$26.4M | -$27.0M | -$60.3M | -$102.7M | -$81.8M | -$90.8M | -$18.9M |
| EBITDA | -$22.6M | -$15.0M | -$18.2M | -$19.2M | -$32.2M | -$53.8M | -$89.0M | -$45.0M | -$56.5M | $10.3M |
| Gastos por Intereses | $7.8M | $3.0M | $3.2M | $2.7M | $2.1M | $251000 | $1.2M | $2.2M | $3.9M | $17.6M |
| Beneficio Antes de Impuestos | -$37.2M | -$24.6M | -$28.0M | -$28.7M | -$40.2M | -$59.2M | -$98.0M | -$66.2M | -$78.6M | -$32.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$37.2M | -$24.6M | -$28.0M | -$28.7M | -$40.2M | -$59.2M | -$98.0M | -$66.2M | -$78.6M | -$33.8M |
| BPA | $-193.52 | $-30.23 | $-5.74 | $-2.58 | $-0.71 | $-0.30 | $-0.44 | $-0.28 | $-0.34 | $-0.14 |
| BPA Diluido | $-193.52 | $-30.23 | $-5.74 | $-2.58 | $-0.71 | $-0.30 | $-0.44 | $-0.28 | $-0.34 | $-0.14 |
| Acciones en Circulación (Diluidas) | $192371 | $814796 | $4.9M | $12.2M | $56.9M | $195.8M | $221.5M | $238.7M | $231.7M | $234.0M |
Precio
| Precio | $1.52 |
| Capitalización | $370M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ADUR · ASIX · GPRE · KOP · KRO · LWLG · LXU
Explorar sector: Basic Materials · Chemicals - Specialty
Más secciones de GEVO: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones